| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Uremia | D014511 | 33 associated lipids |
| Colitis, Ulcerative | D003093 | 24 associated lipids |
| Stomach Ulcer | D013276 | 75 associated lipids |
| Kidney Failure, Chronic | D007676 | 51 associated lipids |
| Nocardia Infections | D009617 | 6 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Graft Occlusion, Vascular | D006083 | 11 associated lipids |
| Hypercalcemia | D006934 | 13 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Dermatitis, Contact | D003877 | 59 associated lipids |
| Bacterial Infections | D001424 | 21 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Autoimmune Diseases | D001327 | 27 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
| Genital Diseases, Female | D005831 | 7 associated lipids |
| Mouth Diseases | D009059 | 5 associated lipids |
| Meningococcal Infections | D008589 | 3 associated lipids |
tacrolimus
Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
Cross Reference
Introduction
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with tacrolimus?
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (2)
- Am. J. Physiol. Renal Physiol. (1)
- Drug Metab. Dispos. (1)
- Others (1)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with tacrolimus
PubChem Associated disorders and diseases
What pathways are associated with tacrolimus
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with tacrolimus?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with tacrolimus?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with tacrolimus?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with tacrolimus?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with tacrolimus?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with tacrolimus
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Hiraga K et al. | A novel screening for inhibitors of a pleiotropic drug resistant pump, Pdr5, in Saccharomyces cerevisiae. | 2001 | Biosci. Biotechnol. Biochem. | pmid:11515543 |
| Shitamukai A et al. | A positive screening for drugs that specifically inhibit the Ca2+-signaling activity on the basis of the growth promoting effect on a yeast mutant with a peculiar phenotype. | 2000 | Biosci. Biotechnol. Biochem. | pmid:11055400 |
| Funabashi H et al. | Glucose oxidase assisted homogeneous electrochemical receptor binding assay for drug screening. | 2006 | Biosens Bioelectron | pmid:16169211 |
| Tajdaran K et al. | A novel polymeric drug delivery system for localized and sustained release of tacrolimus (FK506). | 2015 | Biotechnol. Bioeng. | pmid:25850693 |
| Xia M et al. | Enhanced FK506 production in Streptomyces tsukubaensis by rational feeding strategies based on comparative metabolic profiling analysis. | 2013 | Biotechnol. Bioeng. | pmid:23682004 |
| Qi H et al. | Integration of parallel C-labeling experiments and in silico pathway analysis for enhanced production of ascomycin. | 2017 | Biotechnol. Bioeng. | pmid:27869289 |
| Fu LF et al. | Improvement of FK506 production by synthetic biology approaches. | 2016 | Biotechnol. Lett. | pmid:27600954 |
| Li X et al. | Immunophilin FK506 loaded in chitosan guide promotes peripheral nerve regeneration. | 2010 | Biotechnol. Lett. | pmid:20443046 |
| Gailliot FP et al. | Fluidized bed adsorption for whole broth extraction. | 1990 Sep-Oct | Biotechnol. Prog. | pmid:1366874 |
| Takaori K et al. | A comparative study on immunosuppressive effects of cyclosporin A and FK 506 on peripheral blood lymphocytes in dogs. | 1992 | Biotherapy | pmid:1377926 |
| Edey K et al. | Topical tacrolimus in the management of lichen sclerosus. | 2006 | BJOG | pmid:17176285 |
| Luesley DM and Downey GP | Topical tacrolimus in the management of lichen sclerosus. | 2006 | BJOG | pmid:16827768 |
| Lagoda G et al. | FK506-binding protein localizations in human penile innervation. | 2008 | BJU Int. | pmid:18005210 |
| Koreth J et al. | Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors. | 2009 | Blood | pmid:19713456 |
| Abu Zaid M et al. | Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT. | 2017 | Blood | pmid:27827824 |
| Abdel-Azim H et al. | Expansion of multipotent and lymphoid-committed human progenitors through intracellular dimerization of Mpl. | 2008 | Blood | pmid:18174381 |
| Otto KG et al. | Cell proliferation through forced engagement of c-Kit and Flt-3. | 2001 | Blood | pmid:11369667 |
| Choi SW et al. | Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT. | 2017 | Blood | pmid:28784598 |
| Yoshikawa H et al. | Fc gammaRIII-mediated regulation of hematopoiesis in murine bone marrow cells by interleukin-3 and CD95 (Fas/Apo-1). | 1997 | Blood | pmid:9292524 |
| Jiang H et al. | Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy. | 2006 | Blood | pmid:16868252 |
| Cutler C et al. | Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation. | 2007 | Blood | pmid:17138818 |
| Pulsipher MA et al. | The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial. | 2014 | Blood | pmid:24497539 |
| Khouri IF et al. | Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality. | 2001 | Blood | pmid:11739162 |
| Kharfan-Dabaja MA et al. | Thrombotic microangiopathy after GVHD prophylaxis with tacrolimus/sirolimus: a call for use of consensus definition in reporting. | 2010 | Blood | pmid:20508174 |
| Hirao A et al. | Effects of immunosuppressants, FK506, deoxyspergualin, and cyclosporine A on immature human hematopoiesis. | 1993 | Blood | pmid:7680241 |
| Kriss M et al. | Haploidentical hematopoietic stem cell transplantation for graft-versus-host disease after liver transplantation. | 2011 | Blood | pmid:21940833 |
| Ricciardelli I et al. | Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells. | 2014 | Blood | pmid:25185261 |
| Fay JW et al. | FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation. | 1996 | Blood | pmid:8605372 |
| Nakao A et al. | Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism. | 2006 | Blood | pmid:16638929 |
| Uchida N et al. | Myocardial ischemia following allogeneic bone marrow transplantation: possible implication of tacrolimus overdose. | 2000 | Blood | pmid:10939803 |
| Zoeteweij JP et al. | Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus. | 2001 | Blood | pmid:11290600 |
| Fortin JF et al. | Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1. | 2001 | Blood | pmid:11290602 |
| Peters D et al. | Potentiation of CD3-induced expression of the linker for activation of T cells (LAT) by the calcineurin inhibitors cyclosporin A and FK506. | 2000 | Blood | pmid:10779414 |
| Mehta BA et al. | Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells. | 1995 | Blood | pmid:7579455 |
| Hemenway C | FK506 in bone marrow transplantation. | 1995 | Blood | pmid:7579473 |
| Nash RA et al. | Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. | 2000 | Blood | pmid:10979948 |
| Cutler C et al. | Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. | 2014 | Blood | pmid:24982504 |
| Lee YR et al. | Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. | 2005 | Blood | pmid:15657176 |
| Rodriguez R et al. | A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens. | 2010 | Blood | pmid:19965688 |
| Mouzaki A and Rungger D | Properties of transcription factors regulating interleukin-2 gene transcription through the NFAT binding site in untreated or drug-treated naive and memory T-helper cells. | 1994 | Blood | pmid:7522636 |
| Brewin J et al. | Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. | 2009 | Blood | pmid:19770360 |
| Cunningham EB | An inositolphosphate-binding immunophilin, IPBP12. | 1999 | Blood | pmid:10515881 |
| Joneja U and Uppal G | Pseudo-Pelger-Huët anomaly in a patient on tacrolimus. | 2015 | Blood | pmid:26371350 |
| Arceci RJ et al. | Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. | 1992 | Blood | pmid:1381629 |
| Adachi M et al. | Interleukin-2 (IL-2) upregulates BAG-1 gene expression through serine-rich region within IL-2 receptor beta c chain. | 1996 | Blood | pmid:8943845 |
| Hooijberg E et al. | NFAT-controlled expression of GFP permits visualization and isolation of antigen-stimulated primary human T cells. | 2000 | Blood | pmid:10887106 |
| Przepiorka D et al. | Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation. | 1996 | Blood | pmid:8943876 |
| Nash RA et al. | Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study. | 1995 | Blood | pmid:7540071 |
| Taylor PA et al. | Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions. | 2002 | Blood | pmid:12384443 |
| Hackstein H et al. | Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells. | 2002 | Blood | pmid:12130531 |
| Ratanatharathorn V et al. | Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. | 1998 | Blood | pmid:9746768 |
| Nash RA et al. | FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. | 1996 | Blood | pmid:8896434 |
| Aruch DB and Renteria A | Simultaneous PRES and TMA secondary to tacrolimus after allogeneic bone marrow transplant. | 2015 | Blood | pmid:26287041 |
| Neff T et al. | Pharmacologically regulated in vivo selection in a large animal. | 2002 | Blood | pmid:12200362 |
| Parrow NL and Fleming RE | Releasing the FKBP12 brake on hepcidin. | 2017 | Blood | pmid:29122771 |
| Antin JH et al. | Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation. | 2003 | Blood | pmid:12730113 |
| De Angelis B et al. | Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506). | 2009 | Blood | pmid:19759356 |
| Jin L et al. | Stimulating cell proliferation through the pharmacologic activation of c-kit. | 1998 | Blood | pmid:9446649 |
| Colucci S et al. | The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes. | 2017 | Blood | pmid:28864813 |
| Zhu X et al. | Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults. | 2014 | Blood Cells Mol. Dis. | pmid:24931461 |
| de Cal M et al. | Oxidative stress and 'monocyte reprogramming' after kidney transplant: a longitudinal study. | 2008 | Blood Purif. | pmid:18182807 |
| Arai S and Vogelsang GB | Management of graft-versus-host disease. | 2000 | Blood Rev. | pmid:11124107 |
| Pardi C and Oltean M | An unusual case of red blood cell immunisation following liver transplantation. | 2015 | Blood Transfus | pmid:26057497 |
| Zhang L et al. | Characterization of calcineurin from Cryptococcus humicola and the application of calcineurin in aluminum tolerance. | 2017 | BMC Biotechnol. | pmid:28356086 |
| Becker JC et al. | The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report. | 2006 | BMC Cancer | pmid:16405733 |
| Jia N et al. | Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature. | 2015 | BMC Cancer | pmid:26197890 |
| Buchwald A et al. | Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA. | 2012 | BMC Clin Pharmacol | pmid:22236286 |
| Boms S et al. | Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood. | 2004 | BMC Dermatol. | pmid:15485581 |
| Hiraoka S et al. | The earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patients. | 2015 | BMC Gastroenterol | pmid:25925267 |
| Takazono T et al. | Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report. | 2014 | BMC Infect. Dis. | pmid:24576098 |
| GoranoviÄ D et al. | FK506 biosynthesis is regulated by two positive regulatory elements in Streptomyces tsukubaensis. | 2012 | BMC Microbiol. | pmid:23083511 |
| Jia W et al. | The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms. | 2016 | BMC Microbiol. | pmid:27316338 |
| Hurtgen BJ et al. | Impairment of early fracture healing by skeletal muscle trauma is restored by FK506. | 2017 | BMC Musculoskelet Disord | pmid:28606129 |
| Shimojima Y et al. | Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study. | 2012 | BMC Musculoskelet Disord | pmid:23173570 |
| Birdwell KA et al. | Assessment of arterial stiffness using pulse wave velocity in tacrolimus users the first year post kidney transplantation: a prospective cohort study. | 2015 | BMC Nephrol | pmid:26133166 |
| Chegounchi M et al. | Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation. | 2006 | BMC Nephrol | pmid:16573841 |
| Luo L et al. | Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy. | 2012 | BMC Nephrol | pmid:22747784 |
| Liu S et al. | Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study. | 2015 | BMC Nephrol | pmid:26637482 |
| Yu H et al. | Risk factors for new-onset diabetes mellitus after living donor kidney transplantation in Korea - a retrospective single center study. | 2016 | BMC Nephrol | pmid:27473469 |
| Xie X et al. | mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis. | 2015 | BMC Nephrol | pmid:26126806 |
| Qin HZ et al. | Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients. | 2017 | BMC Nephrol | pmid:28056860 |
| Younas N et al. | HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival. | 2010 | BMC Nephrol | pmid:20359353 |
| Wlodarczyk Z et al. | A multicenter, randomized, double-blind study comparing different FK778 doses (manitimus) with tacrolimus and steroids vs. MMF with tacrolimus and steroids in renal transplantation. | 2012 | BMC Nephrol | pmid:22835011 |
| Gmitterová K et al. | Tacrolimus-induced parkinsonism in a patient after liver transplantation - case report. | 2018 | BMC Neurol | pmid:29678162 |
| Madian AG et al. | Case report: Inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution. | 2014 | BMC Pharmacol Toxicol | pmid:25472557 |
| Neye H and Verspohl EJ | The FK506 binding protein 13 kDa (FKBP13) interacts with the C-chain of complement C1q. | 2004 | BMC Pharmacol. | pmid:15353007 |
| Dury S et al. | Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study. | 2015 | BMC Pulm Med | pmid:26545860 |
| Kato M et al. | Pneumocystis pneumonia induced by treatment with low-dose tacrolimus and methylprednisolone in a patient with rheumatoid arthritis: a case report. | 2013 | BMC Res Notes | pmid:24289285 |
| Hadjipanagi D et al. | Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population. | 2014 | BMC Res Notes | pmid:24593903 |
| Yamada K et al. | Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report. | 2018 | BMC Res Notes | pmid:29338781 |
| Rice SA et al. | Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease. | 2013 | BMC Res Notes | pmid:23331739 |
| Waechter F | Drug company accused of breaking advertising regulations. | 2003 | BMJ | pmid:12763970 |
| Briffa N and Morris RE | Immunosuppressive drugs after lung transplantation. | 1998 | BMJ | pmid:9529396 |
| Knoll GA and Bell RC | Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. | 1999 | BMJ | pmid:10213717 |
| Webster AC et al. | Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. | 2005 | BMJ | pmid:16157605 |
| Iheanacho I | Definitely not acceptable: drug company sues journal over review. | 2011 | BMJ | pmid:21285186 |
| Lapsley P | Itching for a solution. | 2005 | BMJ | pmid:15731120 |
| Ashcroft DM et al. | Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. | 2005 | BMJ | pmid:15731121 |
| Brousse N and Goulet O | Small bowel transplantation. | 1996 | BMJ | pmid:8611766 |
| Allen BR and Luger TA | Risk: benefit ratio is important in treating atopic dermatitis. | 2002 | BMJ | pmid:12399360 |